8-K: Scilex Holding Company Addresses Manipulative Short Selling of its Stock

Scilex Holding Company is taking action against what it believes is manipulative and naked short selling of its common stock, which it believes is negatively impacting shareholder value.

Summary

• Scilex Holding Company has issued a press release addressing concerns about manipulative and naked short selling of its common stock.
• The company believes that approximately 10 million shares are being sold short, and more than 10 million dividend shares have been sold as naked short positions since January 2023.
• Scilex also reports that approximately 44 million shares did not cast votes in the prior two annual meetings, suggesting a failure by brokerage firms to deliver shares.
• The company is providing guidance to shareholders on how to recall loaned shares, demand shares be held in cash accounts, and move shares to a direct registration system.
• Scilex management is determined to combat manipulative and illegal short selling practices that reduce shareholder value and infringe on shareholder rights.

Sentiment

Score: 4

Explanation: The document highlights significant issues with short selling and potential illegal activity, which is negative. However, the company is taking proactive steps to address these issues, which is a positive. Overall, the sentiment is slightly negative due to the severity of the problems.

Positives

• Scilex management is actively addressing concerns about manipulative short selling.
• The company is providing clear guidance to shareholders on how to protect their shares.
• Scilex is communicating with regulatory authorities and pursuing legal processes to expose any manipulative and illegal naked short selling.
• The company is taking steps to enhance stockholder value and protect their stockholder rights.

Negatives

• There is a significant amount of short selling activity in Scilex stock.
• A substantial number of dividend shares have been sold as naked short positions.
• Brokerage firms may have failed to deliver dividend shares to beneficial owners, potentially violating Regulation SHO.
• Shareholders may incur costs when transferring shares out of brokerage accounts.

Risks

• The company faces risks associated with the unpredictability of trading markets.
• There are risks related to the potential product candidates not progressing through clinical development or receiving regulatory approvals.
• Scilex may be unable to successfully market or gain market acceptance of its product candidates.
• The outcomes of trials and studies for SP-102, SP-103, or SP-104 may not be successful.
• There are regulatory and intellectual property risks associated with the company's products.

Future Outlook

Scilex expects to launch Gloperba in the first half of 2024, and is actively working to combat manipulative short selling practices.

Management Comments

• Scilex management is determined to enhance its stockholders value and protect their stockholder rights.
• Scilex Management is determined to combat manipulative and illegal short selling of Scilex common stock which has the effect of reducing shareholder value and infringing on shareholders rights.

Industry Context

The issue of naked short selling is a concern in the broader market, and Scilex's actions are similar to those taken by other companies like Trump Media & Technology Group Corp. to address this issue.

Comparison to Industry Standards

• The company's actions to combat short selling are similar to those taken by Trump Media & Technology Group Corp. (DJT), which also recently advised its shareholders on how to prevent the lending of their shares.
• The level of short selling and potential naked short selling reported by Scilex is significant and warrants the company's proactive response.
• The failure of brokerage firms to deliver dividend shares is a potential violation of Regulation SHO, which is a common concern in the industry.

Stakeholder Impact

• Shareholders are directly impacted by the manipulative short selling and are being advised on how to protect their investments.
• Brokerage firms are implicated in the potential failure to deliver dividend shares and may face regulatory scrutiny.
• The company's reputation and stock price are negatively impacted by the short selling activity.

Next Steps

• Scilex will continue to communicate with regulatory authorities and pursue legal processes to address manipulative short selling.
• Shareholders are encouraged to take steps to protect their shares by recalling loaned shares, holding shares in cash accounts, or moving shares to a direct registration system.
• Scilex expects to launch Gloperba in the first half of 2024.

Key Dates

Keywords

short selling, naked short selling, dividend shares, Regulation SHO, brokerage firms, shareholder value, stockholder rights, SCLX, Scilex, stock lending